Fold change analysis showed that, compared to controls, IDO1 mRNA level increased by 2‐fold while IDO2 mRNA level decreased by 0.37‐fold in NPC patients (Figure 1B). This evidence concerns the gene IDO1 and nasopharyngeal carcinoma.